CD8A and myeloid sarcoma: The frequency of CD8+ T lymphocytes responding to specific EBV-derived epitopes, including EBNA3A (HLA-A2–CLG) and LMP-2 (HLA-B7–RPP), is higher in patients with MS compared with healthy controls44.